Advertisement

Early recurrent pregnancy failure: treatment with human chorionic gonadotrophin

  • R. F. Harrison

Summary

Based upon our present knowledge of the endocrine processes concerned with early pregnancy, the role of exogenous heG in the prevention of habitual abortion has been examined.

A dose regime has been established administering hCG intramuscularly from earliest diagnosis of pregnancy at intervals until 16 weeks gestation.

An open study using hCG in 32 women showed a 6.2% abortion rate. A placebo-controlled study on 20 women gave a significantly better outcome using hCG (p < 0.01). A further placebo-controlled study is ongoing, the extra numbers needed to provide a definitive answer being recruited on a multi centre basis.

Pending the outcome of this study, results to date suggest hCG to be the treatment of choice for habitual abortion where no cause can be found or where a potentially treatable hormonal deficiency is suspected.

Keywords

Early Pregnancy Corpus Luteum Human Chorionic Gonadotrophin Abortion Rate Plasma Progesterone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Davies J, Ryan KJ. Comparative endocrinology of gestation. In: Vitamins and Hormones. (Eds) RF Harris, PL Munsen, E Diczfalusy and J Glover. New York: Academic Press, 1972; pp. 233–279.Google Scholar
  2. 2.
    Corker CS, Michie E, Hobson B, Parboosingh J. Hormonal patterns in conceptual cycles and early pregnancy. Br J Obstet Gynaec 1976; 83: 489–494.CrossRefGoogle Scholar
  3. 3.
    Mishell DR, Thorneycroft IA, Nagata Y, Mirata T, Nakamura RM. Steroid gonadotropin and steroid pattern in early human gestation. ATOG 1973; 117: 631–639.Google Scholar
  4. 4.
    Navot D. Laufer N, Kopolavic J, Rabinowitz R, Burkenfeld A. Lewin A, Granat M, Margaliot E, Shenker JG. Artifically induced endometrial cycles and establishment of pregnancies in the absence of ovaries. New Eng J Med 1986; 314: 806–808.PubMedCrossRefGoogle Scholar
  5. 5.
    Allen WM, Corner GW. Physiology of the corpus luteum. III. Normal growth and implantation of embryos after very early ablation of the ovaries under the influence of extract of the corpus luteum. Am J Physiol 1929; 88: 340–346.Google Scholar
  6. 6.
    McKerns KW. Genetic biochemical and hormonal mechanisms in the regulation of uterine metabolism. In: Cellular Biology of the Uterus. Ed. RM Wynn. New York: Appleton-Century Crofts, 1967; pp. 71–113.Google Scholar
  7. 7.
    Harrison RF, Youssefnejadian E, Brodovcky H, Johnston M, Dewhurst J. Secretion patterns of plasma-progesterone, 17 α-hydroxy-progesterone and 20 α-hydroxy-pregn-4-en-3- one in early normal pregnancy. Br J Obstet Gynaec 1978; 85: 921–926.CrossRefGoogle Scholar
  8. 8.
    Harrison RF, Kitchin Y. Maternal plasma unconjugated oestrogens in early human pregnancy. Br J Obstet Gynaec 1980; 87: 686–694.CrossRefGoogle Scholar
  9. 9.
    Kunz J, Keller PJ. hCG, HPL, oestradiol, progesterone and AFP in serum in patients with threatened abortions. Br J Obstet Gynaec 1976; 83: 640–644.CrossRefGoogle Scholar
  10. 10.
    Herbst AL, Ulfelder H, Poskanzer DG. Adenocarcinoma of the vagina-association of maternal stilboestrol therapy with tumour appearances in young women. N Eng J Med 1971; 284: 878–881.CrossRefGoogle Scholar
  11. 11.
    Yovich JL. Stanger JG, Yovich JM, Tuvik AI. Assessment and hormonal treatment of the luteal phase of in vitro ferilization cycles. Aust NZ J Obstet Gynaec 1984; 24: 125–130.CrossRefGoogle Scholar
  12. 12.
    Shearman RF, Garrett WJ. Double blind study of the effect of 17-hydroxyprogesterone-caproate on abortion rate. Br Med J 1963; 1: 292–295.PubMedCrossRefGoogle Scholar
  13. 13.
    Rosenwaks Z, Donor eggs. Their application in modern reproductive techniques. Fertil Steril 1987; 47: 895–909.PubMedGoogle Scholar
  14. 14.
    Lenton EA, Neal LM, Sulaiman R. Plasma concentration of human chorionic gonadotropin from the time of implantation until the second week of pregnancy. Fertil Steril 1982; 37: 773–778.PubMedGoogle Scholar
  15. 15.
    Harrison RF, O’Moore RR, McSweeney J. Maternal plasma beta-hCG in early human pregnancy. Br J Obstet Gynaec 1980; 87: 705–711.CrossRefGoogle Scholar
  16. 16.
    Hanson FW, Powell JE, Stevens VC. Effects of hCG and human pituitary LH on steroid secretion and functional life of the corpus luteum. J Clin Endocrinol 1971; 32: 211–215.CrossRefGoogle Scholar
  17. 17.
    LeMaire WJ, Rice BF, Savard K. Steroid hormone formation in the human ovary. V. Synthesis of progesterone in vitro in corpora lutea during the reproductive cycle. J Clin Endocrinol 1968; 28: 1249–1256.CrossRefGoogle Scholar
  18. 18.
    Mahadevan MM, Leader A, Taylor PJ. Effects of low dose human chorionic gonadotropin on corpus luteum function after embryo transfer. In Vitro Fert Embryo Transfer 1985; 2: 190–194.CrossRefGoogle Scholar
  19. 19.
    Tulchinsky D, Hobel CJ. Plasma human chorionic gonadotropin, estrone, estradiol, estriol, progesterone and 17 α-hydroxy-progesterone in human pregnancy. III. Early normal pregnancy. Am J Obstet Gynec 1973; 117: 884–892.PubMedGoogle Scholar
  20. 20.
    Yoshimi J, Strott CA. Marshall JR, Lipsett MB. Corpus luteum function in early pregnancy. J Endocrinol 1969; 29: 225–230.Google Scholar
  21. 21.
    Csapo AI, Pulkkinen MO, Kaihola HL. Effective estradiol replacement therapy in early pregnancy lutiectomised patients. Am J Obstet Gynec 1973; 115: 759–765.PubMedGoogle Scholar
  22. 22.
    Diczfalusy E, Troen P. Endocrine functions of the human placenta. Vitamins and Hormones 1979; 19: 229–311.CrossRefGoogle Scholar
  23. 23.
    Moore RM, Rosen L. Corpus luteum ofthe sheep: functional relationship between the embryo and the corpus luteum. J Endocrinol 1965; 34: 233–239.CrossRefGoogle Scholar
  24. 24.
    Dukelow WR. Human chorionic gonadotropin: induction of ovulation in the squirrel monkey. Science 1979; 206: 234–235.PubMedCrossRefGoogle Scholar
  25. 25.
    Garner PR, Armstrong DT. The effect of human chorionic gonadotropin and estradiol 17-β on the maintenance of the human corpus luteum of early pregnancy. Am J Obstet Gynec 1977; 128: 469–475.PubMedGoogle Scholar
  26. 26.
    Sandler SW, Braillie P. The use of human chorionic gonadotrophin in recurrent abortion. S Afr Med J 1979; 55: 832–835.PubMedGoogle Scholar
  27. 27.
    Midgley AR (Jnr), Jaffe RB. Regulation of human gonadotrophins. II. Disappearance of human chorionic gonadotrophin following delivery. J Clin Endocrinol 1968; 28: 1712–1718.CrossRefGoogle Scholar
  28. 28.
    Marshall JR, Hammond CB, Ross GT, Jacobson A, Rayford P, Odell W. Plasma and urinary chorionic gonadotropin during early human pregnancy. Obstet Gynec 1968; 32: 760–764.PubMedGoogle Scholar
  29. 29.
    Deansley R. The endocrinology of pregnancy and fetal life. In: Marshall’s Physiology of Reproduction. Ed. AP Parkes. London: Longhall Green. 1966; p.891.Google Scholar
  30. 30.
    Goldzieher JW. Double blind trial of a progestin in habitual abortion. JAMA 1964; 188: 651–654.PubMedCrossRefGoogle Scholar
  31. 31.
    Chamberlain G. Recurrent miscarriage and pre-term labour. In: Clinics in Obstetrics and Gynaecology. Ed. TMG Harley. London: WB Saunders 1982; Vol. 9. pp. 115–130.Google Scholar
  32. 32.
    Overstreet E. The newer progestins in threatened and habitual abortion. Pac Med Surg 1964; 72: 289–292.PubMedGoogle Scholar
  33. 33.
    Dutinger J, Newmark J, Reinthaller A, Riss P, Muller-Tyle E, Fischl F, Bieglmayer C, Janisch H. Pregnancy specific parameters in early pregnancies after in vitro fertilisation. Prediction of the course of pregnancy. Fertil Steril 1986; 46: 77–80.Google Scholar
  34. 34.
    Stirrat GM. Recurrent abortion-a review. Br J Obstet Gynaec 1983; 90: 881–883.CrossRefGoogle Scholar
  35. 35.
    DeCherney A, Polan ML, Evaluation and managment of habitual abortion, Br J Hosp Med 1984; 31: 261–268.Google Scholar
  36. 36.
    Harrison RF. Treatment of habitual abortion with human chorionic gonadotropin results of open and placebo-controlled studies. Eur J Obstet Gynaec Reprod Biol 1985; 20: 159–168.CrossRefGoogle Scholar
  37. 37.
    Utian WH. Human chorionic gonadotropin in the treatment of threatened and recurrent abortion. A preliminary reappraisal. S Afr Med J 1974; 48: 769–771.PubMedGoogle Scholar
  38. 38.
    Vorster CZ, Pannall PR, Slabber CF. Treatment of threatened and habitual abortion with human chorionic gonadotrophin. S Afr Med J 1977; 51: 165–166.PubMedGoogle Scholar
  39. 39.
    Sandler SW. Spontaneous abortion in perspective. A 7 year study. S Afr Med J 1977; 52: 1115–1118.PubMedGoogle Scholar
  40. 40.
    Goldzieher JW, Benigno B. Treatment of threatened and recurrent abortion: A critical review. Am J Obstet Gynec 1958; 75: 1201–1214.Google Scholar
  41. 41.
    Glass RH, Golbus MS. Habitual abortion. Fertil Steril 1978; 29: 257–265.PubMedGoogle Scholar

Copyright information

© The Royal College of Obstetricians and Gynaecologists 1988

Authors and Affiliations

  • R. F. Harrison

There are no affiliations available

Personalised recommendations